Real-world outcomes of a loading phase with intravitreal faricimab in refractory Neovascular Age-Related Macular Degeneration (nAMD) patients

Real-world outcomes of a loading phase with intravitreal faricimab in refractory Neovascular Age-Related Macular Degeneration (nAMD) patients

Abstract Background Intravitreal injection (IVI) of anti-vascular endothelial growth factor (anti-VEGF) agents is the standard of care for neovascular age-related macular degeneration (nAMD), but treatment resistance and incomplete fluid resolution remain challenges in refractory cases. This study i...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu Yufeng, Hong Ningxi, Su Mingzhi, Zheng Weixin, Ye Panpan
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Ophthalmology
Subjects:
Faricimab
Neovascular age-related macular degeneration (n-AMD)
Anti vascular endothelial growth factor (anti-VEGF)
Angiopoietin 2
Biomarkers
Online Access:https://doi.org/10.1186/s12886-025-04212-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12886-025-04212-7

Similar Items